Abstract
Introduction
Caveolin-1 (cav-1) and cav-2 have been studied exclusively as major structural components of plasma membrane caveolae [1] [2] [3] [4] . Recently, functions of cav-1 outside of caveolae in the plasma membrane have been reported [4] [5] [6] . Distinctively from the caveolae, cav-1 oligomers can form functional microdomains and interact with proteins and lipids to regulate raft dynamics and receptor signalling [5] [6] [7] . Cav-1 has also been shown to be present in the cytoplasm, focal adhesions, mitochondria, lipid droplets and nucleus, suggesting its function in a variety of cell signalling and mechanotransduction processes to regulate tumour cell migration and metastasis [5] [6] [7] [8] [9] [10] . Relative to cav-1, it is reported that cav-2 is not essential for caveolae biogenesis [11, 12] . The functional role of cav-2 in lipid microdomains distinct from caveolae has not been explored. [20] [21] [22] [23] [24] [22, 25, 26] . Each receptor is capable of cross-binding insulin and IGF-1 but binds its own ligand with a 100-1000-fold higher affinity than that of the heterologous peptide [27, 28] . Both IR and IGF-1R phosphorylate on tyrosine residues of the same substrates such as insulin receptor substrate (IRS) [29, 30] , Gab-1 [31] and Shc [32] , and activate the Ras-Raf-ERK [33, 34] and phosphoinositide 3-kinase / Akt [35] [20, 22, 23] . We 
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have been investigating insulin action in cellular mitogenesis and have identified a positive regulator, cav-2, of ERK-mediated mitogenic signalling in response to
insulin [13] [14] [15] [13] [14] [15] were grown in DMEM containing 5 mM D-glucose supplemented with 10% (v/v) FBS, 100 nM methotrexate (Sigma-Aldrich) and 0.5% gentamycin (Gibco/BRL) in a 5% CO2 incubator at 37ЊC as previously described [13] [14] [15] 39] . The HEK293T, rat-1, COS-7 and Hirc-B cells express both IR and IGF-1R and are shown to be sensitive to both insulin and IGF-1 [13, 24, [40] [41] [42] [43] [44] 
. However, how differently cav-2-dependent cellular mitogenesis is regulated in response to insulin versus IGF-1 has not been investigated. In this study, we identify a novel domain, Ser
-Val
-Ser 156 in the C-terminal of cav-2 that is required for the nuclear targeting of phospho-ERK in insulin signalling. We demonstrate insulin-specific cav-2-depedent activation of ERK, its interaction with cav-2 and their co-localization in the nuclear envelop distinctive from IGF-1 action.
Materials and methods
Cell culture and treatment
Human embryonic kidney (HEK) 293T cells having no detectable endogenous cav-1 and cav-2 [36, 37] and rat 1 fibroblast and COS-7 (African green monkey kidney) cells endogenously expressing cav-1 and cav-2 [13, 38] were grown in DMEM (Gibco/BRL, Grand Island, NY, USA) containing 5 mM D-glucose supplemented with 10% (v/v) foetal bovine serum (FBS) (Cambrex Bio Science, Verviers, Belgium) and 0.5% penicillin/streptomycin (Sigma-Aldrich, St Louis, MO, USA) in a 5% CO2 incubator at 37ЊC. Human insulin receptor-expressed rat 1 fibroblast (Hirc-B) cells having cav-2 alone
Immunofluorescence and co-localization intensity measurements
Nuclear fractionation
Nuclear fractions were prepared as described [46] Figure 1A . (Fig. 5A) . As shown in Figure 1A , WTcav-2 was re-localized to the nuclear envelope in response to insulin (Fig. 5A, panel 1) . AAA, AVA and AVS mutants were not translocated to the nuclear envelope (Fig. 5A , panels 2-4) whereas SVA mutant was (Fig. 5A, panel 5 Figure 5A , nuclear localization of SVA and ASVS mutants with phospho-ERK was initiated by insulin treatment (Fig. 5B, lanes 12 and 14) . [24, 40, 47] . ERK was associated with cav-2 independently of their phosphorylation [14] (Fig. 6B) . Fig. 6B) , although phosphorylation of ERK was induced by 10 nM IGF-1 (Fig. 6A) . [24, 48] . But 10 nM IGF-1 induced phosphorylation of ERK (Fig. 7A) as previously shown in HEK293T cells [24] . Figure 7A by a 3.4-fold in vector control (Fig. 7B) .
SDS-PAGE and immunoblot analysis
Results
Cav-2 translocation to the nuclear envelope and association with Lamin A/C in the inner nuclear membrane in response to insulin
We have previously demonstrated that cav-2 is translocated with phospho-ERK to the nucleus in response to insulin in Hirc-B cells [13-15]. When immunostaining of the nuclear localized cav-2 was examined using confocal microscopy in cav-2-transfected HEK293T cells, the cav-2 displayed a strong signal in the region of nuclear envelope in response to insulin as compared to control (Fig. 1A). Analysis of changes in height of peaks in surface plots of cav-2 FI showed that insulin induced translocation of cav-2 to the nuclear envelope. Quantitation of cav-2 FI using line profile analysis re-confirmed the nuclear envelope targeted cav-2 in response to insulin (Fig. 1A). As nuclear fraction of cav-2-transfected HEK293T cells was subjected to immunoprecipitation analysis, cav-2 interaction not only with lamin A/C but also with phospho-ERK was increased by insulin in the nucleus (Fig. 1B). The insulin-induced increase in cav-2 interaction with lamin A/C was observed in Hirc-B and Rat-1 cells. Insulin up-regulated association between lamin A/C and phospho-ERK as well (Fig. 1C). Confocal microscopic image analysis showed that cav-2 was distributed throughout intracellular compartments in control cells as observed in
Insulin, however, induced a profound change in localization of cav-2 to nuclear envelope and increased co-localization of cav-2 with lamin A/C in the inner nuclear membrane in Hirc-B and COS-7 cells (Fig. 1D). The quantitative correlation analysis showed the expected increase in the inner nuclear membrane co-localization (%) from merge intensity of cav-2 with lamin A/C staining (54.8% and 57.2% increases in Hirc-B and COS-7 cells, respectively). Quantitative line profile analysis confirmed that cav-2 was co-localized with lamin A/C in the inner nuclear membrane in response to insulin in Hirc-B (Fig. 1D, panels a and b) and COS-7 (Fig. 1D, panels c and d) cells. These results verify that insulin translocates cav-2 to the nuclear envelope and the cav-2 is subsequently localized to the inner nuclear membrane where cav-2, phospho-ERK and lamin A/C interact together.
Prevention of nuclear localization of cav-2 and phospho-ERK by deletion of amino acids 120-162 at the C-terminus
Requirement of amino acids 120-162 at the C-terminus of cav-2 for insulin-induced phosphorylation of pY19-cav-2 and cav-2 interaction with phospho-ERK
S153A mutant), SAS mutant was not but ASVS mutant translocated to the nuclear envelope in response to insulin (Fig. 5A, panels 6 and 7). Analysis of changes in height of peaks in surface plots of the cav-2 FI confirmed the retardation of nuclear envelope translocation of the AAA, AVA, AVS and SAS mutants, and translocation of WTcav-2 and SVA and ASVS mutants to the nuclear envelope in response to insulin (Fig. 5A). When effects of the various mutants were further examined for insulin-induced nuclear localization of cav-2 and phospho-ERK by nuclear fractionation, WT-cav-2 and phospho-ERK were predominantly detected in membrane and cytoplasmic fractions, respectively, in untreated cells and their localization to nucleus was significantly increased by insulin treatment (Fig. 5B, lanes 1 and 2). AAA, AVA, AVS and SAS mutants were not
Fig. 3 Retardation of insulin-induced phosphorylation of pY19-cav-2 and ERK, interaction of cav-2 with phospho-ERK, and nuclear translocation of cav-2 by deletion of C-terminal domain (residues 120-162). Hirc-B cells expressing pDS_FLAG-XB vector, FLAG-cav-21-162, or FLAG-cav-21-119 mutant were treated with or without insulin (100 nM) for 10 min. (A) WCL were subjected to immunoblotting using antibodies specific for pY19-cav-2, cav-2, phospho-ERK, ERK, cav-1 and actin. Shown is a representative experiment that was repeated three times. (B) WCL were immunoprecipitated with anti-FLAG antibody and subjected to immunoblot analysis with anti-phospho-ERK, anti-ERK and anti-FLAG antibodies as indicated. Interaction of cav-2 with phospho-ERK was quantified by densitometry. The results represent the mean Ϯ S.E. of three independent experiments. (C) Cells were fixed, immunostained with anti-FLAG antibody, and visualized by TRITC-conjugated antibody. DNA was stained using DAPI to visualize the nucleus. Results are representative images of cells from three independent experiments. Red: FLAG; Blue: DAPI; Merge: FLAG ϩ DAPI. Nuclear translocation of FLAG-cav-21-162 and FLAG-cav-21-119 mutant was quantified by the Image Calculator of Image J as described under 'Materials and methods'. Nuclear : cytoplasmic ratios of FLAG staining are shown. detected in nuclear fraction in response to insulin. Insulin-stimulated nuclear localization of phospho-ERK was not observed in the mutant-transfected cells (Fig. 5B, lanes 4, 6, 8 and 10). Consistent with the results in
Together with the results demonstrated in Figures 2-4, these data point out that Ser
-Val
-Ser 156 domain in C-terminal (residues 120-162) of cav-2 is required for phosphorylation of pY19-cav-2 and ERK and its interaction with phospho-ERK, and regulates translocation of cav-2 with phospho-ERK to the nuclear envelope in response to insulin.
Insulin-specific interaction of phospho-ERK with cav-2
To verify association of phospho-ERK with cav-2 is an insulinspecific action in comparison to IGF-1, we examined phosphorylation of ERK and the interaction by insulin versus IGF-1 in Hirc-B cells having endogenous cav-2 alone [13-15]. In response to insulin, phosphorylation of ERK was increased 3.0-, 5.1-and
8.1-fold by 1, 10 and 100 nM insulin, respectively (Fig. 6A). IGF-1 elicited a response at 10 nM concentration, consistent with effects mediated by low affinity binding to IR
In comparison, that interaction of phospho-ERK with cav-2 was increased by 1 and 100 nM insulin, the interaction was not affected by 10 nM IGF-1 (
When the insulin-specific phospho-ERK interaction with cav-2 was examined in COS-7 cells having endogenous cav-1 and cav-2, the interaction was induced by insulin, but not IGF-1 (Fig. 6C). These results demonstrate that ERK is phosphorylated by both insulin and IGF-1, but phosphorylation of ERK in the ERK-cav-2 complex is an insulin-specific signalling event.
Insulin-specific cav-2-dependent activation of ERK and IR
To characterize further the differential effect of insulin and IGF-1 on activation of ERK, HEK293T cells having no detectable endogenous
We next examined the IGF-1-and insulin-induced ERK activation in WT-cav-2-transfected HEK293T cells. IGF-1 treatment showed an increase in ERK activation as observed in
WTcav-2 transfection itself up-regulated phosphorylation of ERK by a 3.5-fold as compared to unstimulated vector control, and ERK
Fig. 6 Insulin-induced interaction of phospho-ERK with cav-2 distinctively from IGF-1. Hirc-B cells were treated with the indicated nanomolar concentration of insulin or IGF-1 for 10 min. (A) WCL were subjected to immunoblot analysis using anti-phospho-ERK, anti-ERK, anti-cav-2, anti-cav-1 and antiactin antibodies. The densitometry ratios of phospho-ERK to total ERK were illustrated. The results represent the mean Ϯ S.E. of three independent experiments. (B) WCL were immunoprecipitated with anti-cav-2 antibody and subjected to immunoblot analysis with anti-phospho-ERK, anti-ERK, anti-cav-2, anti-pY19-cav-2 and anti-cav-1 antibodies as indicated. Shown is a representative experiment that was repeated three times. (C) COS-7 cells were treated with or without IGF-1 (10 nM) or insulin (100 nM) for 10 min. Equal amount of WCL were immunoprecipitated with anti-cav-2 antibody and subjected to immunoblot analysis with anti-phospho-ERK, anti-ERK, anti-cav-2, anti-pY19-cav-2 and anti-cav-1 antibodies as indicated. Shown is a representative experiment that was repeated three times.
activation was increased only by a 1.3-fold upon IGF-1 treatment (Fig. 7B) Figure 7C , almost the same level of insulin-induced phosphorylation was observed. Cav-2 is required for prolonged tyrosine kinase activation of IR [49] . When we investigated insulin-specific (Fig. 7D) . (Fig. 7D) . Thus, these data reveal that rescue of cav-2 loading restores insulin-specific activation of ERK by promoting tyrosine kinase activation of IR. Figure 6B and C. When Figure 8B, re-localize the cav-2 to the nuclear envelope (Fig. 9A, panel 6 ).
cav-2-dependent expression and activation of IR in WT-cav-2-transfected HEK293T cells, expression of IR was not changed
Insulin triggered tyrosine kinase activation of IR by a 5.0-fold in vector control. WT-cav-2 promoted phosphorylation of IR by a 7.6-fold in response to insulin. By contrast, IGF-1-induced IR activation was unchanged by WT-cav-2 transfection
Insulin-specific pY19-cav-2-dependent phosphorylation of ERK
pY19-Cav-2 was phosphorylated by insulin, but not IGF-1 and insulin increased association between cav-2 and phospho-ERK in Hirc-B and COS-7 cells as shown in
HEK293T cells were transfected with WT-cav-2, insulin induced interaction between ERK and pY19-cav-2 (Fig. 8A). To verify if the
Fig. 8 Attenuation of insulin-induced phosphorylation of ERK by Y19A mutant. (A) HEK293T cells expressing pcDNA3 vector or WT-cav-2 were treated with or without IGF-1 (10 nM) or insulin (100 nM) for 10 min. WCL were immunoprecipitated with anti-ERK antibody and subjected to immunoblot analysis with anti-pY19-cav-2 and anti-ERK antibodies as indicated. Interaction of ERK with pY19-cav-2 was quantified by densitometry. The results represent the mean Ϯ S.E. of three independent experiments. (B) Cells were transfected with pcDNA3 vector, WT-cav-2 or Y19A mutant. Thirty-six hours after transfection, the cells were treated with or without insulin (100 nM) for 10 min. WCL were subjected to immunoblotting using antibodies specific for phospho-ERK, ERK, actin, cav-2, pY19-cav-2 and cav-1. The densitometry ratios of phospho-ERK to total ERK were illustrated. The results represent the mean Ϯ S.E. of four independent experiments. insulin-specific ERK activation requires insulin-induced phosphorylation of cav-2 at tyrosine 19, cells were transfected with Y19A mutant. As shown in
Quantitative line profile analyses of cav-2 and phospho-ERK FI
showed the co-localization of phospho-ERK with cav-2 in the nuclear envelope in response to insulin, but not IGF-1 (Fig. 9A, panels a- (Fig. 6A) [13] [14] [15] (Fig. 7A) [36, 37] . Our investigation showed that insulin-induced activation and nuclear translocation of ERK are dependent on cav-2 irrespective of cav-1 expression (Figs 6-9 ). Cav-2 knockout mice showed pulmonary defects without change in cav-1 protein expression [11] and displayed hyperproliferative phenotype in the lung endothelial cells [52] . Thus [17] . The present data demonstrate that insulin-specific nuclear translocation of phospho-ERK requires cav-2 and that the nuclear localized phospho-ERK with cav-2 associates with lamin A/C in the inner nuclear membrane (Figs 1 and 9 [13] [14] [15] .
How does cav-2 move into the nucleus? It has been well documented that movements of caveolin-containing vesicles are controlled by microtubules [56, 57] . Our investigation of the nuclear trafficking of cav-2 has shown that cav-2 is retro-transported to the nucleus through microtubules driven by kinesin molecular motor in response to insulin (Jeong K., Kwon H., Pak Y., manuscript in preparation).
